Products & Services · Revenue
Other products — Revenue
Regeneron Pharmaceuticals Other products — Revenue increased by 3812.5% to $31.30M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase suggests successful commercialization of smaller assets or portfolio diversification, while a decrease may indicate declining legacy product performance or a strategic shift away from non-core therapies.
Detailed definition
This metric represents the aggregate revenue generated from the company's secondary or smaller-scale pharmaceutical prod...
Peer comparison
Peers typically report this as 'Other Revenue' or 'Non-Core Product Sales,' and it is often benchmarked against the contribution of primary blockbuster drugs to total revenue.
Metric ID:
regn_segment_other_products_revenuesHistorical Data
8 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $800.00K | $31.30M |
| QoQ Change | — | — | — | — | — | — | — | >999% |
Range$0.00 – $31.30M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's other products — revenue?
- Regeneron Pharmaceuticals (REGN) reported other products — revenue of $31.30M in Q1 2026.
- What does other products — revenue mean?
- Total revenue generated from the company's secondary pharmaceutical products outside of its primary core franchises.